4/A

PRIMARY DOCUMENT

Company: NovaBay Pharmaceuticals, Inc.
Filed: February 1, 2011
Period of Report: September 5, 2008
Accession Number: 0001437749-11-000584

View Document ↗ View on SEC.gov ↗